Supplemental Material: Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast Cancer

Home administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.

Articles in this issue

---

Use of COTA Nodal Address Highlights Variance in Cancer Care Cost: An Interview With Donald M. Berwick, MD, MPP

Radiation Oncology’s Role in the Next Chapter of Payment Reform

ACCC and ASCO Collaborative Targets Disparities in Cancer Clinical Trials

Flying the Plane While You Build It

The Untapped Potential of Cell and Gene Therapy

Interview: Tanya Siddiqi, MD, Discusses the Promise of Reduced Toxicity With Liso-Cel

FDA Approves Osimertinib for Adjuvant Treatment of Early-Stage EGFR-Mutated NSCLC

Certain NSCLC Patients Are More Likely to Respond to Immunotherapy, Study Results Show

Possible Treatment Identified for Aggressive NSCLC Subset

Contributor: A Practical Path Forward to More Patient-Centered Value Assessment

Proximity to Treatment, Racial Disparities Are Seen in Ovarian Cancer Survival

Lung Cancer Screenings Fall, Biopsy Rates Rise During COVID-19

As Mammography Screenings Drop, Advanced Breast Cancer Cases Increase in First Months of COVID-19

Azacitidine Is Shown to Improve Overall, Relapse-Free Survival in Older Adults With AML

FDA Updates Ibrutinib Label With 5-Year Data in Waldenström Macroglobulinemia

Related Videos

Related Content

Advertisement

December 17th 2024

A Standardized Care Pathway Increases Optimal Dialysis Starts

Roy G. Marcus, MD David M. Miller, MBA Brian H. Nathanson, PhD Douglas Eckhardt, MBA Steven Henry, PharmD Katherine Kwon, MD Rohit Sharma, MD Nirav Vakharia, MD

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.

March 26th 2024

Exploring Medicare Advantage Prior Authorization Variations

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.

December 16th 2024

Addressing STIs Through Managed Care: Opportunities in Medicaid and Beyond

Naomi Seiler, JD Katie Horton, JD, RN, MPH Paige Organick-Lee, MPH Mekhi Washington, BS Taylor Turner, MPH William S. Pearson, PhD, MHA

Medicaid and other managed care organizations could take several key steps to respond to the sexually transmitted infection (STI) epidemic in the US, including congenital syphilis.

August 1st 2023

Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology

Maggie L. Shaw

Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

December 13th 2024

Provider Capacity During Medicaid Expansion and a Public Health Emergency

Jake Haselswerdt, PhD Kristi Ressel, MPH Emmie Harcourt, MPA Sara Gable, PhD Kathleen Quinn, PhD

This survey study finds that most Missouri Medicaid providers had capacity for new patients, even during a period of unprecedented Medicaid enrollment growth.

December 12th 2024

Transforming Kidney Care: Policy, Risk Stratification, and Collaborative Models

Kyle Munz

Experts at a recent Institute for Value-Based Medicine event emphasized the importance of early intervention, policy innovation, and proactive collaboration to transform the management of kidney disease and optimize patient outcomes.

Related Content

Advertisement

December 17th 2024

A Standardized Care Pathway Increases Optimal Dialysis Starts

Roy G. Marcus, MD David M. Miller, MBA Brian H. Nathanson, PhD Douglas Eckhardt, MBA Steven Henry, PharmD Katherine Kwon, MD Rohit Sharma, MD Nirav Vakharia, MD

The authors observed a significant increase in optimal starts for dialysis and in peritoneal dialysis rates after implementing a standardized end-stage renal disease transition pathway.

March 26th 2024

Exploring Medicare Advantage Prior Authorization Variations

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.

December 16th 2024

Addressing STIs Through Managed Care: Opportunities in Medicaid and Beyond

Naomi Seiler, JD Katie Horton, JD, RN, MPH Paige Organick-Lee, MPH Mekhi Washington, BS Taylor Turner, MPH William S. Pearson, PhD, MHA

Medicaid and other managed care organizations could take several key steps to respond to the sexually transmitted infection (STI) epidemic in the US, including congenital syphilis.

August 1st 2023

Oncology Onward: A Conversation With Dr Debra Patt of Texas Oncology

Maggie L. Shaw

Debra Patt, MD, PhD, MBA, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for episode 2 of our newest podcast, "Oncology Onward: Conversations With Innovators and Changemakers in Cancer Care."

December 13th 2024

Provider Capacity During Medicaid Expansion and a Public Health Emergency

Jake Haselswerdt, PhD Kristi Ressel, MPH Emmie Harcourt, MPA Sara Gable, PhD Kathleen Quinn, PhD

This survey study finds that most Missouri Medicaid providers had capacity for new patients, even during a period of unprecedented Medicaid enrollment growth.

December 12th 2024

Transforming Kidney Care: Policy, Risk Stratification, and Collaborative Models

Kyle Munz

Experts at a recent Institute for Value-Based Medicine event emphasized the importance of early intervention, policy innovation, and proactive collaboration to transform the management of kidney disease and optimize patient outcomes.